Evangelia Bolli
- Immunology top 5%
- Immune cells in cancer 7
- Phagocytosis and Immune Regulation 4
- Immunotherapy and Immune Responses 2
- Oncology top 10%
- CAR-T cell therapy research 2
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 2
-
- Glycosylation and Glycoproteins Research 2
-
- Advanced Fluorescence Microscopy Techniques 2
- Co-authors
- Jo A. Van GinderachterXenia GeeraertsSarah‐Maria FendtKiavash MovahediDamya LaouiMáté KissMikäel J. PittetRalph Weissleder
- Partner nations
- BelgiumGermanyUnited States
In The Last Decade
Evangelia Bolli
15 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Immunology 707
- Oncology 420
- Radiology, Nuclear Medicine and Imaging 157
- Cancer Research 102
- Molecular Biology 444
Countries citing papers authored by Evangelia Bolli
This map shows the geographic impact of Evangelia Bolli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelia Bolli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelia Bolli more than expected).
Fields of papers citing papers by Evangelia Bolli
This network shows the impact of papers produced by Evangelia Bolli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelia Bolli. The network helps show where Evangelia Bolli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Evangelia Bolli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A neutrophil response linked to tumor control in immunotherapybreakdown → | 2023 | 229 |
| 2 | 2022 | 73 | |
| 3 | 2022 | 15 | |
| 4 | 2021 | 35 | |
| 5 | 2021 | 60 | |
| 6 | 2020 | 26 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 24 | |
| 9 | 2019 | 79 | |
| 10 | 2019 | 18 | |
| 11 | 2018 | 56 | |
| 12 | 2017 | 246 | |
| 13 | 2017 | 25 | |
| 14 | 2016 | 215 | |
| 15 | 2016 | 47 |
About Evangelia Bolli
Evangelia Bolli is a scholar working on Immunology, Biophysics and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Phagocytosis and Immune Regulation (4 papers), Glycosylation and Glycoproteins Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers) and Advanced Fluorescence Microscopy Techniques (2 papers). The work is most often cited by research in Immunology (707 citations), Oncology (420 citations) and Radiology, Nuclear Medicine and Imaging (157 citations). Evangelia Bolli has collaborated with scholars based in Belgium, Germany and United States. Frequent co-authors include Jo A. Van Ginderachter, Xenia Geeraerts, Sarah‐Maria Fendt, Kiavash Movahedi, Damya Laoui, Máté Kiss, Mikäel J. Pittet, Ralph Weissleder, Jiri Keirsse and Massimiliano Mazzone. Their work appears in journals such as Cell, Nature Communications and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.